Cournoyer, L., Liu, Y., Jaroch, D. B., Hullinger, T. G., Cox, B. F., Katz, S. C., . . . Guha, P. (2025). Pressure enabled drug delivery (PEDD) of nelitolimod increased therapeutic delivery, reduced immunosuppression, and improved efficacy in porcine and murine liver tumor models. Frontiers in oncology, 15, 1655794. https://doi.org/10.3389/fonc.2025.1655794
Citácia podle Chicago (17th ed.)Cournoyer, Lauren, et al. "Pressure Enabled Drug Delivery (PEDD) of Nelitolimod Increased Therapeutic Delivery, Reduced Immunosuppression, and Improved Efficacy in Porcine and Murine Liver Tumor Models." Frontiers in Oncology 15 (2025): 1655794. https://doi.org/10.3389/fonc.2025.1655794.
Citácia podľa MLA (8th ed.)Cournoyer, Lauren, et al. "Pressure Enabled Drug Delivery (PEDD) of Nelitolimod Increased Therapeutic Delivery, Reduced Immunosuppression, and Improved Efficacy in Porcine and Murine Liver Tumor Models." Frontiers in Oncology, vol. 15, 2025, p. 1655794, https://doi.org/10.3389/fonc.2025.1655794.